ACAD – acadia pharmaceuticals inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ACAD

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/6

12:15 pm

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

2/6

12:15 pm

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

2/6

08:43 am

acad

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Low Report

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "market perform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Report

2/3

11:03 am

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

2/3

11:03 am

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

2/3

08:03 am

acad

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $37.00 price target on the stock.

Medium Report

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $37.00 price target on the stock.

Report

1/6

01:35 pm

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

1/6

01:35 pm

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

1/6

12:17 pm

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

1/6

07:07 am

acad

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at Citigroup Inc..

Medium Report

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at Citigroup Inc..

Report

1/5

08:42 am

acad

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.

Low Report

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.

Report

12/15

10:05 am

acad

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Low Report

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

12/11

08:14 am

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

12/4

01:01 pm

acad

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at UBS Group AG.

Low Report

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at UBS Group AG.

Report

12/2

10:16 am

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

12/2

10:16 am

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

11/17

12:23 pm

acad

Rating for ACAD

Low Report

Rating for ACAD

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.